Risk-Based Validation: Why “Everything Doesn’t Need Validation” in Pharma & Life Sciences
Risk-Based Validation In today’s digital pharma ecosystem, companies are rapidly adopting electronic systems, automated workflows, AI-driven QMS platforms, and cloud-based applications. But with increasing complexity comes a crucial question: Do all systems require full validation?The answer — backed by global regulatory expectations — is no.This is where Risk-Based Validation (RBV) becomes a strategic advantage. Regulators […]
Understanding the Validation Lifecycle (URS → PQ)
The validation lifecycle is a critical concept in Computer System Validation (CSV) and Quality Systems. Whether you’re in pharmaceuticals, biotech, medical devices, or regulated digital health, understanding the lifecycle from User Requirements Specification (URS) to Performance Qualification (PQ) is essential for compliance, audit readiness, and product integrity. The goal is simple: prove that a computerized […]
Why FDA 21 CFR Part 11 Still Matters in 2026
Why FDA 21 CFR Part 11 Still Matters in 2026 As the life sciences industry accelerates digital transformation, the importance of FDA 21 CFR Part 11 compliance has never been more relevant. Introduced to regulate electronic signatures and electronic records, this framework ensures data accuracy, authenticity, and traceability in highly regulated environments such as pharmaceutical […]
